Annals of the Rheumatic Diseases (ARD) is a scholarly journal dedicated to publishing research in the field of Medicine. BMJ is the publisher of this esteemed journal. The P-ISSN assigned to Annals of the Rheumatic Diseases is 0003-4967 and its abbreviated form is Ann Rheum Dis.
nnals of the Rheumatic Diseases (ARD) is an international peer review journal committed to promoting the highest standards of scientific exchange and education. It covers all aspects of rheumatology, which includes the spectrum of musculoskeletal conditions, arthritic disease, and connective tissue disorders. ARD publishes basic, clinical, and translational scientific research. Annals of the Rheumatic Diseases is the flagship of BMJ’s rheumatology portfolio and has two companion journals: RMD Open for original research in rheumatology and musculoskeletal disorders and Lupus Science & Medicine for original research in lupus and related diseases.
Journal title | Annals of the Rheumatic Diseases (ARD) |
Abbreviation | Ann Rheum Dis |
Print ISSN | 0003-4967 |
Online ISSN | 1468-2060 |
Publisher Name | BMJ |
Editor-in-chief | Josef Smolen, Medical University of Vienna Vienna, Austria |
Subject Category | Medicine |
Abbreviation : ISO Journal abbreviation refers to the shortened form or acronym used to represent the full title of a scholarly journal. The ISO4 Abbreviation of Annals of the Rheumatic Diseases Journal is Ann Rheum Dis.
The Ranking of the Journal in 2024 is 166. Ranking systems aim to provide an indication of a journal's quality, influence, and prestige within a specific field or discipline.
The Journal's Impact Factor in 2024 is 27.4. it is all calculated by Clarivate, which means how many times a particular citation has been published in the past two years.
The Journal SCImago in 2024 is 6.489. It is measured by the number of citations which are made by the particular journals, and the journal from where the citations arrived from.
The Acceptance Rate in 2024 is 15%%. It is a measure that provides insight into the selectivity and competitiveness of a journal's editorial process.
The Journal's H-Index in 2024 is 272. The H-index is calculated on how many times a particular author is cited and the number of published papers that a particular author has.
The Journal's Quartile is Q1. A quartile has three points, which are the upper quartile, median, and lower quartile. The main motive of the quartile is to calculate the interquartile range, that resembles the changes across the median.
The Journal is indexed in (Indexing details)
PubMed | Scopus | Web of Science | UGC | Embase | DOAJ |
---|---|---|---|---|---|
✅ | ✅ | ✅ | ✅ | ✅ | ❌ |
Indexing services aim to make it easier for researchers, scholars, and readers to discover and access articles from various journals within a specific field or discipline.
Abbreviation | Ann Rheum Dis |
Access type | Open Access |
Acceptance rate | 15%% |
Impact Factor | 27.4 |
SJR | 6.489 |
SNIP | 5.147 |
Ranking | 166 |
CiteScore | 32.8 |
H-Index | 272 |
The Editor-in-chief of the Journal is Josef Smolen, Medical University of Vienna Vienna, Austria
Processing/Submission Fee : Article submission/Processing fees (APC), also known as manuscript Publication fees or processing fees (APC), are charged by journals to authors for submitting/publishing their research papers/article.
The APC/Submission (Publication) Fee of the Journal is 3,090 GBP
Call for paper : The Journal invites original research contributions for consideration of publication in Annals of the Rheumatic Diseases journal.
Journal seeking submissions in the broad areas of Medicine that align with journal's focus on Medicine.
for details about call for paper please visit to the official website of the journal to check the details about call for papers.
Publishing in Annals of the Rheumatic Diseases involves the following steps:
Yes, the journal is indexed in PubMed.
Yes, the journal is indexed in Scopus.
Yes, the journal is indexed in UGC.
No, the journal is not indexed in Index copernicus.
No, journal is not a predatory journal.
The Impact Factor of the Journal is 27.4.
The Ranking of the Journal is 166.
Yes the journal is a peer-reviewed journal.
Yes the journal is a peer-reviewed journal and good to publish your paper.
Yes, Annals of the Rheumatic Diseases is a open access journal.